Pharmaceuticals
Lupin, BC Partners shortlisted for Bayer’s $1.1 bn dermatology business
14 Oct 2016
Lupin is mainly attracted by the Bayer dermatology business's regional presence in North America, where it is keen to expand
NPPA caps prices of 31 essential drugs
10 Oct 2016
Mylan to pay $465 mn to settle DoJ probe over EpiPen costs
08 Oct 2016
Generic and specialty pharmaceuticals company Mylan NV yesterday agreed to pay $465 million to settle allegations of overcharging the US government on its Medicaid program for its EpiPen products

